# Examination of Psychotropic Medication Use Following Outpatient Behavioral Assessment and Treatment

## TL;DR

This study found that children with neurodevelopmental disorders often start or increase psychotropic medications over time after behavioral treatment.

## Contribution

The study provides new insights into medication use patterns following outpatient behavioral treatment in children with neurodevelopmental disorders.

## Key findings

- Children were more likely to start new psychotropic medications or increase doses over time.
- Fewer children remained on the same medication regimen as when they first visited the clinic.
- Caregivers were generally satisfied with the clinic, but medication changes still occurred.

## Abstract

Background/Objectives: Psychotropic medications are often prescribed to treat challenging behavior in children with neurodevelopmental disorders. This study examined patterns of psychotropic medication use following outpatient behavioral assessment and treatment in children ages 2–16 years. Methods: Medication use at the time of behavioral assessments, six months after the assessment, and a later follow-up time point (mean 25 months following the six-month time point, range 1 month to 41 months) were evaluated via a chart review. Alterations in psychotropic medication use were grouped into eight categories according to the type of medication change experienced. Care providers also completed a social validity survey rating their satisfaction with the assessment and interventions developed for their child. Results: This retrospective study revealed that children in this sample were more likely to experience starting a new medication and increases in the dose of psychotropic medication as time passed. Children were also less likely to remain on the same regimen of psychotropic medication as when they were first seen in the clinic. Additionally, although caregivers generally rated their experiences and outcomes with the behavioral clinic as favorable, additions and increases to psychotropic medication regimens still occurred. Conclusions: These findings are consistent with other reports of continued and increased prescribing of psychotropic medication across time in children with neurodevelopmental disorders, however, the results must be interpreted with caution given the small sample size which limits generalizability of these findings. Additionally, the lack of follow-up with the patients in this sample made it difficult to correlate changes in challenging behavior with psychotropic medication prescribing.